Form 4: National Healthcare Corp Director Adams Receives Stock Option Grant

Director Robert G. Adams of National Healthcare Corp received a stock option grant on May 9, 2024, for 7,500 shares of common stock.

Summary

• Robert G. Adams, a director at National Healthcare Corp (NHC), reported a transaction involving derivative securities.
• On May 9, 2024, Adams was granted an option to purchase 7,500 shares of NHC common stock at an exercise price of $96.03.
• These options vest on May 9, 2025, and expire on May 8, 2029.
• Adams also directly owns options to purchase 7,500 shares from grants in 2021, 2022 and 2023.
• Adams also indirectly owns 430,341 shares of common stock through a partnership and 6,079 shares through a trust.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of a stock option grant, which is generally neutral. The grant itself could be seen as a positive sign of confidence in the company's future, but it's a standard practice.

Positives

• The option grant aligns the director's interests with those of the shareholders, incentivizing him to work towards increasing the company's stock value.

Industry Context

Stock option grants are a common practice in the healthcare industry to incentivize executives and align their interests with shareholders.

Comparison to Industry Standards

• Stock option grants are a common form of compensation for directors in publicly traded companies, including those in the healthcare sector.
• The size of the grant (7,500 shares) and the exercise price ($96.03) would need to be compared against similar grants at comparable companies to determine if it is in line with industry standards.
• Companies like Brookdale Senior Living and LifePoint Health also utilize stock options as part of their executive compensation packages.

Stakeholder Impact

• The stock option grant could potentially benefit shareholders if the director's performance leads to an increase in the company's stock price.

Key Dates